Rhizen Pharmaceuticals
As of the edition of 20 October 2026, Rhizen Pharmaceuticals runs 5 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 1 |
| Stopped | 3 |
| Status not established | 1 |
| Total | 5 |
Where its trials are
- Cancer: 13 trials led
- Blood and lymph: 10 trials led
- Immune system: 9 trials led